Andrade D M, Zumsteg D, Hamani C, Hodaie M, Sarkissian S, Lozano A M, Wennberg R A
Division of Neurology, Krembil Neuroscience Centre, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
Neurology. 2006 May 23;66(10):1571-3. doi: 10.1212/01.wnl.0000206364.19772.39. Epub 2006 Mar 15.
The authors describe long-term follow-up (mean, 5 years) in patients with anterior (AN) (n = 6) or centromedian (n = 2) thalamic deep brain stimulation (DBS) for epilepsy. Five patients (all AN) had > or = 50% seizure reduction, although benefit was delayed in two until years 5 to 6, after changes in antiepileptic drugs. DBS electrode implantation in AN patients was followed by seizure reduction 1 to 3 months before active stimulation, raising the possibility of a beneficial microthalamotomy effect.
作者描述了对接受丘脑前核(AN,n = 6)或中央中核(n = 2)深部脑刺激(DBS)治疗癫痫患者的长期随访(平均5年)。5例患者(均为AN)癫痫发作减少≥50%,尽管有2例患者在调整抗癫痫药物后,直到第5至6年才出现疗效。AN患者植入DBS电极后,在开始积极刺激前1至3个月癫痫发作减少,这增加了有益的微丘脑切开术效应的可能性。